You are about to leave the Valneva UK Limited healthcare website and will be directed to the Moskito Guard® consumer website. This site is also maintained by Valneva.

Please note that all videos hosted on the Moskito Guard® website can only be viewed via You Tube.

Valneva are not responsible for the content provided by linked sites.

Continue Cancel

You are about to leave the Valneva UK Limited healthcare website and will be directed to the Moskito Guard® consumer website. This site is also maintained by Valneva.

Please note that all videos hosted on the Moskito Guard® website can only be viewed via You Tube.

Valneva are not responsible for the content provided by linked sites.

Continue Cancel

You are about to leave the Valneva UK website and will be directed to the Beware of the Bugs website. This site is also maintained by Valneva.

Please note that all videos hosted on the Beware of the Bugs website can only be viewed via You Tube.

Valneva are not responsible for the content provided by linked sites.

Continue Cancel

I confirm that I am a healthcare professional

Yes No

I confirm that I am a healthcare professional

Yes No

I re-confirm that I am a healthcare professional. Please note that we do not accept orders from members of the public

Continue Cancel

Sorry, there has been an error

OK

Are you sure?

Unsubscribing means you will no longer receive the very latest information concerning our portfolio of products and services.

Continue Back

IXIARO® is the only licensed and recommended Japanese encephalitis (JE) vaccine in the UK1

  • Licensed for adults and children 2 months of age and older1,2
  • Results in rapid protection from JE after the second dose (>97% seroconversion), providing a protective response that lasts for at least 12 months2,3
  • Has a well established tolerability profile in adults and children4
  • Available as pre-filled syringes and administered as a two dose schedule:
    • Rapid schedule (for 18 – 65 years of age only): day 0 and
      day 72
    • Conventional schedule: day 0 and day 282
  • A booster dose should be given to adults and children 2 months of age and older within the second year (i.e. 12 – 24 months), prior to potential re-exposure to the JE virus2
  • A second booster dose should be given to adults 18 years of age and above 10 years after the first booster dose, prior to potential re-exposure to the JE virus2
Place an order View PI

How you should administer IXIARO®2

How image How image

Please refer to the IXIARO® Summary of Product Characteristics for more information.

Further information for healthcare professionals